Recent progress in postoperative nausea and vomiting after thyroidectomy - Summary - MDSpire

Recent progress in postoperative nausea and vomiting after thyroidectomy

  • By

  • Qihao Zhao

  • Fuling Song

  • Meimei Cui

  • Haoping Jia

  • Rongzhan Fu

  • Guanghan Wu

  • Dongsheng Zhou

  • July 8, 2026

  • 0 min

Share

Objective:

To summarize recent progress in the epidemiology, mechanisms, risk assessment, prevention, and treatment of postoperative nausea and vomiting (PONV) following thyroidectomy.

Approach:
  • Risk Assessment: Comprehensive risk assessments and individualized antiemetic strategies are essential for effectively reducing PONV.
  • Prophylactic Strategies: Evidence-based multimodal prophylactic strategies include total intravenous anesthesia (TIVA), opioid-sparing techniques, and intraoperative administration of serotonin receptor antagonists and corticosteroids, as supported by current consensus guidelines and randomized controlled trials.
Key Findings:
  • PONV occurs in approximately 30%-40% of patients undergoing general surgery, rising to nearly 80% in high-risk individuals.
  • In thyroidectomy patients, PONV incidence can reach 60%-84% without effective prophylactic strategies.
  • Risk factors for PONV include female sex, non-smoking status, history of motion sickness, and exposure to volatile anesthetics or opioids.
Interpretation:

A better understanding of PONV mechanisms may facilitate individualized risk stratification and optimize perioperative care.

Limitations:
  • Existing literature inadequately addresses thyroidectomy-specific risk factors such as vagal nerve stimulation and neck positioning.
Conclusion:

This review provides practical strategies to reduce PONV incidence in thyroidectomy patients.

Original Source(s)

Related Content